Clinical trials for rare diseases are growing in Italy. The number of trials in these diseases has grown over time from 66 authorized in 2010 (10% of the total number of clinical trials) to 216 in 2019 (32.1%). Almost 82% is supported by drug companies. We won’t stop until rare diseases are even rarer. #rarediseaseday2021 #wewontrest